World Acceptance Corporation (WRLD) is a small-cap subprime consumer installment lender — ≈4.5M shares, limited analyst coverage, no options market. On May 22, 2026, it paid a consent fee to its six-bank lender syndicate to reduce the Fixed Charge Coverage Ratio covenant for three consecutive quarters. The stock is at $166, RSI 92, P/E 24x. Those two facts are not compatible.

What the Filing Says

Item 1.01 — a material definitive agreement, not a press release. The "Consent and Limited Modification to Fixed Charge Coverage Ratio" reduces the FCCR floor from the original 2.25x to:

• Q ending Mar 31, 2026: 2.20x
• Q ending Jun 30, 2026: 2.10x (deepest relaxation)
• Q ending Sep 30, 2026: 2.15x
• Dec 31, 2026 and after: reverts to 2.25x

Company paid a consent fee (0.03% of aggregate commitments) to Bank of Montreal (agent), Axos, First Horizon, Texas Capital, SouthState, and Wells Fargo. Filed May 26 — 52 days into Q1 FY2027 (the quarter ending June 30). Management had April and May actuals when they sought this waiver. They sought it anyway.

The underlying cause is in the April 30 earnings release. FY2026 net income: $35M vs $90M prior year (-61%). G&A as a percent of revenue: 51.5% vs 42.7% (+880bps). Personnel expense: $200M vs $141M (+41.8%). ROE: 9% vs 21%. LTM FCCR reconstruction implies roughly 1.70-1.75x — well below the original 2.25x threshold.

Q4 FY2026 (the most recent quarter) recovered: $36.5M net income, G&A/revenue improving to 45.9%. The problem is that the LTM window still carries the dead weight of Q1-Q3 FY2026, when the company was running near breakeven. Rolling off those quarters into FY2027 is the recovery path. But management has April/May and still needed the waiver.

One partial positive. Delinquency improved: 0-60 day recency down from 18.7% to 17.0%, 61+ down from 6.0% to 5.6%. The caveat: new customer mix was deliberately cut from 9.9% to 8.2% of the portfolio over the same period — fewer new customers mechanically improves portfolio delinquency. Refinance volume surged 26.9% YoY ($470.6M). The improvement is real but partially a mix-shift artifact.

The capital allocation reads as contradictory. FY2026 buybacks: $132M (16.5% of outstanding shares retired). Q4 alone: $37.8M. The same revolver that required a covenant waiver funded the buybacks. $12.2M of authorization remains.

What the Market Thinks

$166, RSI 92.4, +6.9% WTD, P/E 23.88x. Peer RM (Regional Management) trades at 7.18x P/E with clean covenants, improving fundamentals, and personnel costs running DOWN 4.3% YoY in Q1 2026. WRLD carries a 3.3x multiple premium over its direct comp.

Backing out the market-implied probability distribution from the $166 price (recovery scenario $185, second waiver $110, breach $55):

The gap on recovery probability: 43 percentage points.

Forward EV on a long at $166: 0.35×(+11%) + 0.40×(−34%) + 0.25×(−67%) = −26% over 9 months.

Why the Gap Exists

Item 1.01 filings are systematically underread relative to earnings press releases. On a 4.5M float name with no dedicated sell-side coverage, a binding lender consent agreement filed on a Tuesday does not get synthesized within the week. The market is reading the delinquency improvement headline (real, partial) and pricing full recovery. It has not priced the forward-looking signal embedded in what management told six banks: we cannot meet our income coverage ratio for the next two quarters.

Controlling shareholder context is also absent from the recovery narrative. Prescott General Partners sold a $60M block back to the company at $172.88 in September 2025 — funded by the same revolver now under waiver — and sold $60M more in the open market concurrently. The CEO, CFO, and another officer all sold in December 2025 when the stock was around $120. Prescott exited at a 44% premium to where the stock traded in February; it sits 3.5% below their block exit price today.

Risks

Squeeze risk (immediate). 10.5% short interest on a 4.5M float, RSI 92, and $12.2M of buyback authorization still providing technical demand. The squeeze setup here is real — high short interest, thin float, and active buyback demand is a dangerous combination even with a correct thesis on fundamentals.

Personnel costs normalize faster than expected. Management announced ≈$1M/month salary reduction. If field incentives also compress and headcount attrition takes hold, the G&A gap closes toward RM's 44-45% ratio without further announced cuts. This is the primary lever for FCCR recovery.

Sector credit tailwind is genuine. RM, OMF, OPRT all showing delinquency improvement in Q1 2026. If WRLD's charge-offs decline 100-150bps in FY2027 ($12-19M pretax improvement), that alone materially narrows the FCCR gap. The delinquency improvement is not pure noise.

December reversion math is achievable. For FCCR to reach 2.25x by Dec 31, the LTM only needs to generate roughly $8-9M per quarter in Q1-Q3 FY2027 net income — a low bar if Q4 FY2026's $36.5M is the new run rate. The waiver may be precautionary rather than distress.

Catalysts

~Mid-June 2026: $12.2M buyback authorization exhausts at Q4 pace (≈19 trading days). Primary technical demand support disappears. Entry window opens.

August 2026: Q1 FY2027 earnings. First hard test of the 2.10x floor. If FCCR comes in at 2.10-2.12x (tight), the second waiver thesis gains probability. If it misses, an Item 1.01 breach event likely gaps the stock before the entry.

December 31, 2026: FCCR reversion to 2.25x. Hard binary — recovery confirmed or second waiver filed.

What Would Change Our Mind

Recovery: Q1 FY2027 results showing G&A/revenue below 44% (down 7.5pp from the FY2026 full-year rate) AND FCCR meeting the relaxed 2.10x floor with meaningful buffer (2.18x+). That would indicate the announced right-sizing is closing more than 35% of the FCCR gap and the Dec reversion is on track.

Personnel specifics: If Q1 FY2027 personnel expense falls below $42M/quarter (down from $50M Q4 FY2026), the cost structure is genuinely normalizing. That single line item resolves most of the uncertainty.

Prescott increases its stake. The controlling shareholder moving from seller to buyer at current prices — funded with their own capital, not the company's revolver — would signal they see value below $172.88.

Evidence